Works matching IS 17555914 AND DT 2018 AND VI 36 AND IP 5

Results: 12

TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure‐induced stress in mice.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12462
By:
- Eblimit, Zeena;
- Thevananther, Sundararajah;
- Karpen, Saul J.;
- Taegtmeyer, Heinrich;
- Moore, David D.;
- Adorini, Luciano;
- Penny, Daniel J.;
- Desai, Moreshwar S.
Publication type:
Article
Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta‐analysis.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12461
By:
- Yuan, Rong;
- Xin, Qiqi;
- Shi, Weili;
- Liu, Wei;
- Lee, Simon‐M.;
- Hoi, Puiman;
- Li, Lin;
- Zhao, Jun;
- Cong, Weihong;
- Chen, Keji
Publication type:
Article
Obstacles to mineralocorticoid receptor antagonists in a community‐based heart failure population.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12459
By:
- Jonsson, Anna;
- Norberg, Helena;
- Bergdahl, Ellinor;
- Lindmark, Krister
Publication type:
Article
Trimetazidine suppresses oxidative stress, inhibits MMP‐2 and MMP‐9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12460
By:
- Gong, Wei;
- Ma, Youcai;
- Li, Aobo;
- Shi, Han;
- Nie, Shaoping
Publication type:
Article
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case‐control study.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12458
By:
- Zanella, Luca;
- Zoppellaro, Giacomo;
- Marigo, Lucia;
- Denas, Gentian;
- Padayattil Jose, Seena;
- Pengo, Vittorio
Publication type:
Article
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12457
By:
- Ge, Zhen;
- Faggioni, Michela;
- Baber, Usman;
- Sartori, Samantha;
- Sorrentino, Sabato;
- Farhan, Serdar;
- Chandrasekhar, Jaya;
- Vogel, Birgit;
- Qadeer, Abdul;
- Halperin, Jonathan;
- Reddy, Vivek;
- Dukkipati, Srinivas;
- Dangas, George;
- Mehran, Roxana
Publication type:
Article
Predicting long‐term ischemic events using routine clinical parameters in patients with coronary artery disease: The OPT‐CAD risk score.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12441
By:
- Han, Yaling;
- Chen, Jiyan;
- Qiu, Miaohan;
- Li, Yi;
- Li, Jing;
- Feng, Yingqing;
- Qiu, Jian;
- Meng, Liang;
- Sun, Yihong;
- Tao, Guizhou;
- Wu, Zhaohui;
- Yang, Chunyu;
- Guo, Jincheng;
- Pu, Kui;
- Chen, Shaoliang;
- Wang, Xiaozeng
Publication type:
Article
Cost‐effectiveness analysis of biodegradable polymer versus durable polymer drug‐eluting stents incorporating real‐world evidence.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12442
By:
- Teng, Monica;
- Zhao, Ying Jiao;
- Khoo, Ai Leng;
- Ananthakrishna, Rajiv;
- Yeo, Tiong Cheng;
- Lim, Boon Peng;
- Chan, Mark Y.;
- Loh, Joshua P.
Publication type:
Article
Statins and substantially increased ALT values at baseline.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12444
By:
- Athyros, Vasilios G.;
- Katsiki, Niki;
- Mikhailidis, Dimitri P.
Publication type:
Article
Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12440
By:
- Zhu, Pei;
- Tang, Xiaofang;
- Xu, Jingjing;
- Song, Ying;
- Liu, Ru;
- Zhang, Yin;
- Gao, Lijian;
- Gao, Zhan;
- Chen, Jue;
- Yang, Yuejin;
- Gao, Runlin;
- Xu, Bo;
- Yuan, Jinqing
Publication type:
Article
Lipid‐lowering therapy with PCSK9‐inhibitors in the real‐world setting: Two‐year experience of a regional lipid clinic.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12439
By:
- Zafrir, Barak;
- Jubran, Ayman
Publication type:
Article
Issue Information.
Published in:
Cardiovascular Therapeutics, 2018, v. 36, n. 5, p. 1, doi. 10.1111/1755-5922.12297
Publication type:
Article